The DOI matches its Crossref record; 52 of the 60 references it cites were found in a registry or an index.
Brca1 Controls Homology-Directed DNA Repair
Open accessAbstract
Germline mutations in BRCA1 confer a high risk of breast and ovarian tumors. The role of BRCA1 in tumor suppression is not yet understood, but both transcription and repair functions have been ascribed. Evidence that BRCA1 is involved in DNA repair stems from its association with RAD51, a homolog of the yeast protein involved in the repair of DNA double-strand breaks (DSBs) by homologous recombination. We report here that Brca1-deficient mouse embryonic stem cells have impaired repair of chromosomal DSBs by homologous recombination. The relative frequencies of homologous and nonhomologous DNA integration and DSB repair were also altered. The results demonstrate a caretaker role for BRCA1 in preserving genomic integrity by promoting homologous recombination and limiting mutagenic nonhomologous repair processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tumor suppressor complex BRCA1-BARD1 functions in DNA double-strand break repair by homologous recombination.”
From BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing (2017) · cites this paper as [18]
Citations
Cites
3 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
Self-citationRetractedCressman, V. L., Backlund, D. C., Avrutskaya, A. V., Leadon, S. A., Godfrey, V., & Koller, B. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7061 · Cited by 108
Self-citationRetractedLeadon, S. A., & Avrutskaya, A. V. (1997) · PubMed · Cited by 78
RetractedThe double-strand-break repair model for recombination
Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J., & Stahl, F. W. (1983) · Cell · doi:10.1016/0092-8674(83)90331-8 · Cited by 2,437
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
XRCC3 promotes homology-directed repair of DNA damage in mammalian cellsPreprint
Pierce, A. J., Johnson, R. D., Thompson, L. H., & Jasin, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2633 · Cited by 1,384
Self-citationKinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
The Genetic Basis of Human Cancer
Vogelstein, B., & Kinzler, K. W. (1997) · Cited by 1,120
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,087
Xu, X., Ohler, Z. W., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., & Deng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819
Cited by
Sorted by citations
Items 901–999 of 999
Double-Strand Break Repair and Homologous Recombination in Mammalian Cells
Jasin, M. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-095-7_9 · Cited by 9
Self-citationImpairment of homologous recombination control in a Fanconi anemia‐like Chinese Hamster Cell mutant
Larminat, F., Germanier, M., Papouli, E., & Defais, M. J. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.06.001 · Cited by 11
Mechanisms of Repair of Interstrand Crosslinks in DNA
Legerski, R. J., & Richie, C. T. (2002) · Cancer treatment and research · doi:10.1007/978-1-4615-1173-1_6 · Cited by 10
Nyberg, K. A., Michelson, R. J., Putnam, C. W., & Weinert, T. A. (2002) · Cited by 10
BRCA1 and BRCA2 in DNA Repair and Genome Stability
Brenneman, M. A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-095-7_10 · Cited by 10
Li, S., Tang, M., Xiong, Y., Feng, X., Wang, C., Nie, L., Huang, M., Zhang, H., Yin, L., Zhu, D., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03108-y · Cited by 10
DNA Damage Response Pathways and Cancer
Ford, J. M., & Kastan, M. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00011-6 · Cited by 9
BRCA1 Silencing Is Associated with Failure of DNA Repairing in Retinal Neurocytes
Chen, P., Hu, H., Chen, Z., Cai, X., Zhang, Z., Yang, Y., Yu, N. H., Zhang, J., Xia, L., Ge, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099371 · Cited by 9
Hu, X., Baytak, E., Li, J., Akman, B., Okay, K., Hu, G., Scuto, A., Zhang, W., & Küçük, C. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.01.001 · Cited by 8
Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis
Holmstrom, S. R., Wijayatunge, R., McCrum, K., Mgbemena, V. E., & Ross, T. S. (2019) · iScience · doi:10.1016/j.isci.2019.08.031 · Cited by 8
New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers
Bayley, R., Sweatman, E., & Higgs, M. R. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2022.73 · Cited by 8
Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family
Chan, J. M. K., Clendenning, M., Joseland, S. L., Georgeson, P., Mahmood, K., Joo, J. E., Walker, R., Como, J., Preston, S., Chai, S. M., et al. (2023) · Familial Cancer · doi:10.1007/s10689-023-00351-2 · Cited by 8
Goldmann, J. M., Seplyarskiy, V. B., Wong, W. S. W., Vilboux, T., Neerincx, P. B. T., Bodian, D. L., Solomon, B. D., Veltman, J. A., Deeken, J. F., Gilissen, C., et al. (2018) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000604 · Cited by 8
BRCA1 and BRCA2 in Breast Cancer Predisposition and Recombination Control
Scully, R., & Xie, A. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048771.93906.3e · Cited by 8
BRCA-1, BRCA-2 and Hereditary Breast Cancer
Bove, B. A., Dunbrack, R. L., & Godwin, A. K. (2002) · CRC Press eBooks · doi:10.1201/b14039-20 · Cited by 8
Interactions of the Nijmegen Breakage Syndrome Protein with ATM and BRCA1Preprint
Wu, X., Rathbun, G. A., Lane, W. S., Weaver, D. T., & Livingston, D. M. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.535 · Cited by 8
Tumor homologous recombination deficiency assays: another step closer to clinical application?
Stecklein, S. R., & Sharma, P. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0409-7 · Cited by 8
The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance
Carloni, V., Morganti, E., Galli, A., & Mazzocca, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010245 · Cited by 7
Li, Y., He, R., Qin, X. Y., Zhu, Q., Ma, L., & Liang, X. (2024) · PeerJ · doi:10.7717/peerj.17251 · Cited by 8
Concomitant Pathogenic Mutations and Fusions of Driver Oncogenes in Tumors
Zhang, R., Dong, L., & Yu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.544579 · Cited by 7
LARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis
Zhang, F., Yan, P., Yu, H., Le, H., Li, Z., Chen, J., Liang, X., Wang, S., Wei, W., Liu, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108058 · Cited by 7
Wark, L., Novak, D. J., Sabbaghian, N., Amrein, L., Jangamreddy, J. R., Cheang, M., Pouchet, C., Aloyz, R. S., Foulkes, W. D., Mai, S., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22045 · Cited by 8
Postiglione, I., Chiaviello, A., & Palumbo, G. A. (2009) · Medical Oncology · doi:10.1007/s12032-009-9241-9 · Cited by 7
Identification of Genes Regulating Gene Targeting by a High-Throughput Screening Approach
Delacôte, F., Perez, C., Guyot, V., Mikonio, C., Potrel, P., Cabaniols, J., Delenda, C., Pâques, F., & Duchateau, P. N. (2011) · Journal of Nucleic Acids · doi:10.4061/2011/947212 · Cited by 8
Genomic Instability in Cancer Development
Jeggo, P. A. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_6 · Cited by 7
Trafalis, D. T., Polonifi, A., Dalezis, P., Nikoleousakos, N., Katsamakas, S., & Sarli, V. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13006 · Cited by 7
Genetic instability in the RAD51 and BRCA1 regions in breast cancer
Nowacka‐Zawisza, M., Bryś, M., Romanowicz‐Makowska, H., Kulig, A., & Krajewska, W. M. (2006) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-006-0063-x · Cited by 7
McCullough, S. D., Hu, Y., & Li, R. (2007) · Cancer metastasis · doi:10.1007/978-1-4020-5867-7_3 · Cited by 7
Hereditary Ovarian Cancer: Biology, Response to Chemotherapy and Prognosis
Safra, T. (2009) · Women s Health · doi:10.2217/whe.09.40 · Cited by 7
Recent advances in breast cancer biology
Unger, M., & Weber, B. L. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200011000-00002 · Cited by 7
Myriad factors and pathways influencing tumor radiotherapy resistance
Mi, L., & Zhang, H. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0992 · Cited by 8
Chung, S. X., Shahar, S., Singh, D. K. A., Rivan, N. F. M., Karim, N. A., Fuad, N. F. N., Ong, Y. Q., Arifin, A., & Rahni, A. A. A. (2026) · European Journal of Nutrition · doi:10.1007/s00394-025-03845-0 · Cited by 9
Węsierska‐Gądek, J., & Heinzl, S. (2014) · Journal of Cancer Prevention · doi:10.15430/jcp.2014.19.2.125 · Cited by 6
Matthäus, T., Stößer, S., Seren, H. Y., Haberland, V. M. M., & Hartwig, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814395 · Cited by 6
Role of BRCA1 in glioblastoma etiology
Harbi, E., & Aschner, M. (2024) · Cellular Oncology · doi:10.1007/s13402-024-01024-7 · Cited by 6
Why variant effect predictors and multiplexed assays agree and disagree
Livesey, B., & Marsh, J. A. (2026) · Nature Communications · doi:10.1038/s41467-026-77211-x · Cited by 8
Machine-learning of complex evolutionary signals improves classification of SNVs
Labes, S., Stupp, D., Wagner, N., Bloch, I., Lotem, M., Levy‐Lahad, E., Polak, P. P., Pupko, T., & Tabach, Y. (2022) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqac025 · Cited by 6
Classen, S., Rahlf, E., Jungwirth, J., Albers, N., Hebestreit, L. P., Zielinski, A., Poole, L., Groth, M., Koch, P., Liehr, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113363 · Cited by 7
Guo, F., Li, C., Liu, S., Li, Z., Zhai, J., Wang, Z., & Xu, B. (2023) · Cancer Innovation · doi:10.1002/cai2.65 · Cited by 6
Mórocz, M., Qorri, E., Pekker, E., Tick, G., & Haracska, L. (2023) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2023.12.001 · Cited by 7
Veremeyeva, G. A., Akushevich, I. V., Ukraintseva, S. V., YASHIN, A. I., Епифанова, С. Б., Андреевна, Б. Е., & Akleyev, А. V. (2010) · International Journal of Low Radiation · doi:10.1504/ijlr.2010.032771 · Cited by 6
The Biology of Heat-induced DNA Double-Strand Breaks
Mori, E., Takahashi, A., & Ohnishi, T. (2008) · Thermal Medicine · doi:10.3191/thermalmed.24.39 · Cited by 6
dos Santos, J. S., Zunta, G. L., Negrini, A. B., Ribeiro, M. S. G., Martinez, C. A. R., Ribeiro, M. L., Lourenço, G. J., & Ortega, M. M. (2020) · Tumor Biology · doi:10.1177/1010428320923856 · Cited by 6
Association between BRCA mutations and endometrial carcinoma: a systematic review with meta-analysis
Lu, G., Lu, T., Pan, J., Guo, L., Pang, Y., & Liu, P. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05887-7 · Cited by 6
Role of DNA methylation in genome stability
Kovalchuk, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00023-4 · Cited by 8
Parvin, J. D., Chiba, N., & Ransburgh, D. J. R. (2011) · Journal of Visualized Experiments · doi:10.3791/2468-v · Cited by 6
In Vitro Reconstitution of BRCA1-BARD1/RAD51-Mediated Homologous DNA Pairing
Wang, M., Rogers, C. M., Alimbetov, D. S., & Zhao, W. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2063-2_13 · Cited by 6
Brca1 is involved in tolerance to adefovir dipivoxil‑induced DNA damage
Liu, H., Wu, Y., He, F., Cheng, Z., Zhao, Z., Xiang, C., Feng, X., Bai, X., Takeda, S., Wu, X., et al. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4164 · Cited by 6
Elevated radiation-induced γH2AX foci in G2 phase heterozygous BRCA2 fibroblasts
Beucher, A., Deckbar, D., Schumann, E., Krempler, A., Frankenberg-Schwager, M., & Löbrich, M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.043 · Cited by 7
BRCA1: A locus‐specific “liaison” in gene expression and genetic integrity
Aiyar, S. E., Sun, J., & Li, R. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20386 · Cited by 6
Neurodegeneration from Drugs and Aging‐Derived Free Radicals
Ramkissoon, A., Shapiro, A. M., Loniewska, M. M., & Wells, P. G. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch10 · Cited by 6
Insights into the targeted elimination of BRCA1‐defective cancer stem cells
Somasundaram, V., & Srinivas, P. (2010) · Medicinal Research Reviews · doi:10.1002/med.20229 · Cited by 5
FAM20A: a potential diagnostic biomarker for lung squamous cell carcinoma
Zhang, Y., Sun, Q., Liang, Y., Yang, X. F., Wang, H., Song, S., Wang, Y., & Feng, Y. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1424197 · Cited by 5
Awaji, A. A., Maigoro, A. Y., Aborode, A. T., Akintola, A. A., Fatoba, D. O., Idris, E. B., Idris, A. B., Jafri, S., Shoaib, E. A., Onifade, I. A., et al. (2024) · Genome Instability & Disease · doi:10.1007/s42764-024-00133-9 · Cited by 5
Becker, A. A., Graeser, M., Landwehr, C., Hilger, T., Baus, W. W., Wappenschmidt, B., Meindl, A., Weber, R. G., & Schmutzler, R. K. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2119-0 · Cited by 5
Resistance to PARP Inhibitors Mediated by Secondary BRCA1/2 Mutations
Dhillon, K. K., & Taniguchi, T. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-14151-0_18 · Cited by 5
SYK expression level distinguishes control from BRCA1-mutated lymphocytes
Zahavi, T., Sonnenblick, A., Shimshon, Y., Kadouri, L., Peretz, T., Salmon, A. Y., & Salmon‐Divon, M. (2018) · Cancer Management and Research · doi:10.2147/cmar.s156359 · Cited by 5
Inhibiteurs de PARP dans les cancers du sein : développement clinique actuel et perspectives
Robbe, J., Moretta, J., Vicier, C., Sabatier, R., Noguès, C., & Gonçalvès, A. (2020) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.07.011 · Cited by 7
Familial Breast Cancer - Targeted Therapy in Secondary and Tertiary Prevention
Kast, K., & Rhiem, K. (2015) · Breast Care · doi:10.1159/000380756 · Cited by 5
Lajus, T. B. P. (2010) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v9i3.5167 · Cited by 5
Masso, M., Bansal, A., Bansal, A., & Henderson, A. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106442 · Cited by 5
Clear, A. D., Manthey, G. M., Lewis, O., Lopez, I. Y., Rico, R., Owens, S. N., Negritto, M. C., Wolf, E. W., Xu, J. Z., Kenjić, N., et al. (2020) · Microbial Cell · doi:10.15698/mic2020.10.732 · Cited by 5
Molecular pathways involved in cell death after chemically induced DNA damage
Sánchez‐Olea, R., Calera, M. R., & Degterev, A. (2009) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-7643-8336-7_8 · Cited by 5
The absence of a functional relationship between ATM and BLM, the components of BASC, in DT40 cells
Wang, W., Seki, M., Otsuki, M., Tada, S., Takao, N., Yamamoto, K.-I., Hayashi, M., Honma, M., & Enomoto, T. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.11.008 · Cited by 5
Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families
Kim, T., Lee, K.-M., Choi, C. H., Lee, J., Lee, J., Bae, D., & Kim, B. (2006) · Oncology Reports · doi:10.3892/or.15.3.565 · Cited by 5
DNA Repair: A RIDDLE at a Double-Strand Break
Hiom, K. J. (2009) · Current Biology · doi:10.1016/j.cub.2009.03.024 · Cited by 5
Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
Kargaran, P. K., Yasaei, H., Anjomani‐Virmouni, S., Mangiapane, G., & Slijepčević, P. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22386 · Cited by 5
DNA Damage Response Pathways and Cancer
Ford, J. M., & Kastan, M. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50013-0 · Cited by 5
Human DNA polymerase ε : expression, phosphorylation and protein-protein interactions
Tuusa, J. T. (2001) · Cited by 5
Predicting breast cancer therapeutic response
Garrido-Castro, A. C., & Winer, E. P. (2018) · Nature Medicine · doi:10.1038/s41591-018-0033-7 · Cited by 5
Porter, A. C. G. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0622 · Cited by 5
Epigenetic regulation of BRCA1 expression and its role inbreast cancer stem cell development
Shestakova, E. A. (2016) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1507-145 · Cited by 4
Anagho, H. A., Mullari, M., Mattanovich, M., Cho, H., Pedersen, A.-K., Palasca, O., Olsen, J. V., Locard‐Paulet, M., & Nielsen, M. L. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101034 · Cited by 5
BRCA2-dependent maturation of nascent strands during DNA replication
Milano, L., Wells, S. E., Vaitsiankova, A., Drummond‐Clarke, L., Zhu, X., Carreira, A., Kanemaki, M. T., & Caldecott, K. W. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.03.012 · Cited by 4
Jaworski, D., Brzoszczyk, B., & Szylberg, Ł. (2023) · Cells · doi:10.3390/cells12101375 · Cited by 4
Adaptive and Maladaptive DNA Breaks in Neuronal Physiology and Alzheimer’s Disease
Roberts, A., Swerdlow, R. H., & Wang, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147774 · Cited by 4
Thirty years since the race to the BRCA1 gene
Ashworth, A. (2024) · Nature · doi:10.1038/d41586-024-03358-6 · Cited by 4
HELZ is a RNA-DNA helicase that resolves R loops to facilitate homologous recombination repair
Haji‐Seyed‐Javadi, R., Koyen, A. E., Rath, S. K., Wu, B., Madden, M. Z., Hou, Y., Kapoor-Vazirani, P., Roshika, R., Aiello, M., Luong, N. C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75089-3 · Cited by 4
Ovarian Cancer: BRCA Genetics Reveals Targets for New Therapies
Artioli, G. (2014) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000209 · Cited by 4
Abnormalities in DNA double-strand break response beyond primary immunodeficiency
Nakada, S. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0836-5 · Cited by 4
PARP Inhibition as a Prototype for Synthetic Lethal Screens
Liu, X. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-311-4_9 · Cited by 4
Genomic Destabilization Triggered by Replication Stress during Senescence
Minakawa, Y., Shimizu, A., Matsuno, Y., & Yoshioka, K. (2017) · Cancers · doi:10.3390/cancers9110159 · Cited by 4
PET Imaging of PARP Expression Using 18 F-Olaparib
Chen, D. L. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.219733 · Cited by 4
A narrative review of biomarkers in advanced triple negative breast cancer
Chehade, R., Awan, A. A., & Fernandes, R. (2021) · Precision Cancer Medicine · doi:10.21037/pcm-20-76 · Cited by 4
Wu, H., Li, J., Li, J.-Z., Zhai, Q., Ye, J., Zheng, S., & Fang, K. (2023) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v15.i2.142 · Cited by 4
Brca1 Mouse Models: Functional Insights and Therapeutic Opportunities
Yueh, W.-T., Glass, D. J., & Johnson, N. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168372 · Cited by 4
Singh, K., Baird, M. A., Fischer, R. S., Chaitankar, V., Seifuddin, F., Chen, Y.-C., Tunc, I., Waterman, C. M., & Pirooznia, M. (2020) · Cancers · doi:10.3390/cancers12020458 · Cited by 4
BRCA2: safeguarding the genome through homologous recombination
Christ, N., Moynahan, M. E., & Jasin, M. (2007) · Topics in current genetics · doi:10.1007/4735_2007_0216 · Cited by 6
Self-citationBouley, J., Pionneau, C., Varinot, J., Biard, D. S. F., Genestie, C., Antoine, M., Coulet, F., Stern, M., Stoppa‐Lyonnet, D., & Soubrier, F. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900107 · Cited by 4
Evaluation of Homologous Recombinational Repair in Chicken B Lymphoma Cell Line, DT40
Kitao, H., Hirano, S., & Takata, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-129-1_17 · Cited by 4
Biology and Treatment of Basal-Like Breast Cancer
Han, B., Audeh, W., Jin, Y., Bagaria, S. P., & Cui, X. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-634-4_5 · Cited by 4
Bases génétiques de la radiosensibilité des cancers du sein
Delaloge, S., & Marsiglia, H. R. (2005) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2004.11.003 · Cited by 4
Multiplying functions for BRCA1 and BRCA2?
Venkitaraman, A. R. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00007-x · Cited by 4
Venkitaraman, A. R. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.567 · Cited by 4
Chakraborty, P., & Hiom, K. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.20.884593 · Cited by 4
Li, P., Ye, J., Yang, Q., Wang, N., Li, C., Zou, X., Luo, H.-Y., Pan, Y., Jiang, L., Shen, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62295-8 · Cited by 3
Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution
Mangkusaputra, V., Murachelli, A. G., Yu, Z., den Hollander, A., Menafra, R., Schreuder, A., Kloet, S. L., Sixma, T. K., & Noordermeer, S. M. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf848 · Cited by 7
Priya, Kumar, R., & Kumar, D. (2025) · 3 Biotech · doi:10.1007/s13205-024-04195-0 · Cited by 4
Application of Gene Editing Technology Based on Targeted Delivery Materials in TNBC
Qu, P., Li, X., Liu, J., Su, X., Han, S., Wang, Y., Luo, Y., Li, J., Ma, C., Deng, S., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c01294 · Cited by 4
Metadata
- Authors
- Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Jasin, Maria
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 1999-10
- Volume
- 4
- Issue
- 4
- Pages
- 511-518
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2059365987
- Cited by
- 1,245
- References
- 60
- Citations by year
- 2026: 27 · 2025: 18 · 2024: 22 · 2023: 35 · 2022: 21 · 2021: 42 · 2020: 47 · 2019: 48 · 2018: 53 · 2017: 47 · 2016: 47 · 2015: 45 · 2014: 55 · 2013: 58 · 2012: 47
- FWCI
- 22.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- National Cancer Institute (1P50CA68425, P50CA068425)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, homologous recombination, homology-directed repair, DNA double-strand break repair, RAD51, non-homologous end joining, genome stability, tumor suppression, mouse embryonic stem cells, germline mutations, breast and ovarian cancer
- MeSH terms
- Animals, Arabinofuranosyluracil, Cell Line, Chromosomes, DNA Damage, DNA Repair, DNA-Binding Proteins, Mutation, Proto-Oncogene Proteins, Recombination, Genetic, Stem Cells, Thymidine Kinase, Transfection, Retinoblastoma Protein, Mice, Knockout, Gene Targeting, BRCA1 Protein, Rad51 Recombinase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review